Navigation Links
Cord Blood America Enters Agreement With Regence, Serving BlueCross and BlueShield Programs in the Northwest U.S. and Mountain Regions
Date:7/5/2011

LAS VEGAS, July 5, 2011 /PRNewswire/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI) announced today it has entered into an agreement with Regence (www.regence.com/index.jsp) to offer the storage of umbilical cord blood to members of its BlueCross and BlueShield plans in Idaho, Oregon, Utah and Washington at a discount rate consistent with its other BlueCross BlueShield (BCBS) licensee contracts.

The partnership gives Regence members considering cord blood banking access to discounts on CorCell's Saving Baby's Cord Blood program. "This addition to our member discount program gives members another tool to help them make informed health care choices for their families," said Chris Smith, Regence Specialty Business Manager.

"We are pleased to be participating in the Regence member discount program, Regence Advantages," said Erin Tecca, Cord Blood America Business Development Manager.

"Our relationships with BlueCross BlueShield programs across the country have proven both a popular benefit for their members and an excellent way to grow Cord Blood America," said Matthew Schissler, Cord Blood America co-founder and CEO.

Cord blood stem cells, which are collected at birth, are used today to treat more than 70 diseases including leukemia, severe anemia, metabolic blood disorders and immune deficiencies, while research is ongoing to determine the usefulness of stem cells in combating some of the nation's most serious diseases, including diabetes, heart disease, Parkinson's and other diseases for which there is currently no cure.

About Regence

Regence is a nonprofit total health solutions company based in the Pacific Northwest/Intermountain region. Through insurance, wellness, and consumer engagement products and services, Regence promotes health and helps people make informed decisions about their health care.  Regence health insurance plans serve nearly 2.3 million members in Oregon, Washington (select counties), Idaho and Utah.  Regence health insurance plans are independent licensees of the Blue Cross and Blue Shield Association. For more information, please visit www.regence.com.

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.

CONTACT: Paul Knopick
949.707.5363
pknopick@eandecommunications.com


'/>"/>
SOURCE Cord Blood America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Cord Blood America Enters Agreement With Horizon Healthcare Services, Inc. to Offer Stem Cell Collection Services to Its Members
2. BioLife Solutions Now The Leading Supplier of Pre-Formulated GMP Cryopreservation Media for Umbilical Cord Blood Stem Cells
3. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2011
4. China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2011 Financial Results
5. OVA1 Blood Test Detects Ovarian Cancer More Accurately Than Medically Accepted CA 125 Method for Evaluating Women with Ovarian Mass
6. Cord Blood America Reduces "Afford-A-Cord" Program Charges; New Buyers Anticipated
7. Cord Blood America Announces BioCells, Inc., Which it Acquired in 2010, is Opening Office in Miami, Florida and 5 New Offices in Argentina Soon
8. Cord Blood America Announces Reverse Stock Split Takes Effect Monday, May 9, 2011
9. ThermoGenesis Announces China Customer Implements Cord Blood Products
10. Cord Blood America: Shareholders Approve Common Stock Reverse Split
11. Ridge Diagnostics, Inc. Clinical Data on Blood Test for Depression to be Presented at the American Psychiatric Association Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced ... this eBook by providing practical tips, tools, and strategies for clinical researchers. , ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:6/22/2016)... 2016 On Monday, the Department of Homeland ... share solutions for the Biometric Exit Program. The Request ... Protection (CBP), explains that CBP intends to add biometrics ... the United States , in order to deter ... Logo - http://photos.prnewswire.com/prnh/20160622/382209LOGO ...
(Date:6/9/2016)... innovation leader in attendance control systems is proud to announce the introduction of fingerprint ... sure the right employees are actually signing in, and to even control the opening ... ... ... Photo ...
(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
Breaking Biology News(10 mins):